Skip to main content
Fig. 4 | BMC Urology

Fig. 4

From: Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global Registry

Fig. 4

EPIC-26 domain scores of patients who underwent Active Surveillance (Spain did not have patients in this treatment group). Differences across countries were statistically significant in all EPIC-26 scores (p < 0.001). Legend: The upper and lower whiskers represent scores outside the middle 50%, but within 1.5 times the interquartile range above the upper quartile and below the lower quartile (Q1—1.5 * IQR or Q3 + 1.5 * IQR)

Back to article page